Dr. Mary Cunningham, M.D.
Claim this profileState University of New York Upstate Medical University
Area of expertise
Ovarian Cancer
Mary Cunningham, M.D. has run 9 trials for Ovarian Cancer. Some of their research focus areas include:
Fallopian Tube Cancer
Mary Cunningham, M.D. has run 6 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Affiliated Hospitals
State University Of New York Upstate Medical University
SUNY Upstate Medical University
Clinical Trials Mary Cunningham, M.D. is currently running
Tailored Therapy
for Endometrial Cancer
This phase II trial tests how well tailoring therapy in post-surgery works in patients with low-risk endometrial cancer. The usual approach for patients with low-risk endometrial cancer is treatment with surgery. In this study, tissue that is removed as part of the surgical procedure is analyzed in the pathology laboratory to help guide the doctor to decide whether or not additional treatment such as radiation and or chemotherapy should be recommended.
Recruiting
1 award
Phase 2
4 criteria
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting
1 award
Phase 2
More about Mary Cunningham, M.D.
Clinical Trial Related
2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Mary Cunningham, M.D. has experience with
- Paclitaxel
- Olaparib
- Letrozole
- Carboplatin
- Selumetinib Sulfate
- Ipatasertib
Breakdown of trials Mary Cunningham, M.D. has run
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Ovarian Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary Cunningham, M.D. specialize in?
Mary Cunningham, M.D. focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Mary Cunningham, M.D. currently recruiting for clinical trials?
Yes, Mary Cunningham, M.D. is currently recruiting for 6 clinical trials in Syracuse New York. If you're interested in participating, you should apply.
Are there any treatments that Mary Cunningham, M.D. has studied deeply?
Yes, Mary Cunningham, M.D. has studied treatments such as Paclitaxel, Olaparib, Letrozole.
What is the best way to schedule an appointment with Mary Cunningham, M.D.?
Apply for one of the trials that Mary Cunningham, M.D. is conducting.
What is the office address of Mary Cunningham, M.D.?
The office of Mary Cunningham, M.D. is located at: State University of New York Upstate Medical University, Syracuse, New York 13210 United States. This is the address for their practice at the State University of New York Upstate Medical University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.